Publications:

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity.

Cancers

Cabral, Loraine Kay D LKD; Tiribelli, Claudio C; Sukowati, Caecilia H C CHC

Publication Date: 2020-06-15

Variant appearance in text: EGFR: M947T

PubMed Link: 32549224

Variant Present in the following documents:

• Main text
• cancers-12-01576.pdf

View BVdb publication page

HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant.

Cell & Bioscience

Sueangoen, Natthaporn N; Tantiwetrueangdet, Anchalee A; Panvichian, Ravat R

Publication Date: 2020

Variant appearance in text: EGFR: M947T

PubMed Link: 32190291

Variant Present in the following documents:

• Main text
• 13578_2020_Article_407.pdf

View BVdb publication page

Missense Mutations in Exons 18-24 of EGFR in Hepatocellular Carcinoma Tissues.

Biomed Research International

Panvichian, Ravat R; Tantiwetrueangdet, Anchalee A; Sornmayura, Pattana P; Leelaudomlipi, Surasak S

Publication Date: 2015

Variant appearance in text: EGFR: 2840T>C; M947T

PubMed Link: 26436086

Variant Present in the following documents:

• Main text
• BMRI2015-171845.pdf

View BVdb publication page

DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets.

Nature Chemical Biology

Kasap, Corynn C; Elemento, Olivier O; Kapoor, Tarun M TM

Publication Date: 2014-08

Variant appearance in text: EGFR: M947T

PubMed Link: 24929528

Variant Present in the following documents:

• NIHMS593232-supplement-1.pdf

View BVdb publication page